Comparison of rate and rhythm control in patients with atrial fibrillation and nonischemic heart failure.

作者: Baris Ökçün , Zerrin Yigit , Alev Arat , M. Serdar Küçükoglu

DOI: 10.1536/JHJ.45.591

关键词:

摘要: Atrial fibrillation (AF) is a very common cardiac arrhythmia with an increased mortality in patients heart failure. Whether the best therapeutic approach to these restore sinus rhythm or adequately control ventricular rate still controversial. The aim of this study was compare both strategies AF and nonischemic One hundred fifty-four duration greater than 48 hours left dysfunction were randomized either (n = 84) 74) group. composite end points embolism, death, exercise capacity. average age 61 ± 10 years group 58 12 (P NS). follow-up period 35 21 months 37 19 In first year study, capacity ejection fraction (LVEF) improved compared LVEF < 0.0001 P 0.0005, respectively). There no statistically significant differences embolic event between two groups rate, especially for death due pump failure, significantly higher at 0.0001). Restoring maintaining had beneficial effect on failure AF.

参考文章(22)
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators, None, A comparison of rate control and rhythm control in patients with atrial fibrillation. The New England Journal of Medicine. ,vol. 347, pp. 1825- 1833 ,(2002) , 10.1056/NEJMOA021328
P E Carson, R D Fletcher, J N Cohn, G R Johnson, L Farrell, W B Dunkman, The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation. ,vol. 87, ,(1993)
DanielL Dries, DerekV Exner, BernardJ Gersh, MichaelJ Domanski, MyronA Waclawiw, LynneW Stevenson, Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials Journal of the American College of Cardiology. ,vol. 32, pp. 695- 703 ,(1998) , 10.1016/S0735-1097(98)00297-6
Thomas J. Wang, Martin G. Larson, Daniel Levy, Ramachandran S. Vasan, Eric P. Leip, Philip A. Wolf, Ralph B. D’Agostino, Joanne M. Murabito, William B. Kannel, Emelia J. Benjamin, Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. ,vol. 107, pp. 2920- 2925 ,(2003) , 10.1161/01.CIR.0000072767.89944.6E
H R Middlekauff, W G Stevenson, L W Stevenson, Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation. ,vol. 84, pp. 40- 48 ,(1991) , 10.1161/01.CIR.84.1.40
Amala Louis, John G.F. Cleland, Sheran Crabbe, Sarah Ford, Simon Thackray, Tim Houghton, Andrew Clark, Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ‐2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001 European Journal of Heart Failure. ,vol. 3, pp. 381- 387 ,(2001) , 10.1016/S1388-9842(01)00149-0
W L Henry, A DeMaria, R Gramiak, D L King, J A Kisslo, R L Popp, D J Sahn, N B Schiller, A Tajik, L E Teichholz, A E Weyman, Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography. Circulation. ,vol. 62, pp. 212- 217 ,(1980) , 10.1161/01.CIR.62.2.212
Sherry J Saxonhouse, Anne B Curtis, Risks and benefits of rate control versus maintenance of sinus rhythm American Journal of Cardiology. ,vol. 91, pp. 27- 32 ,(2003) , 10.1016/S0002-9149(02)03376-3